Computational Medicine and Drug Discovery Software Market to Reach 6.78 Billion USD by 2020 - IndustryARC Research

News provided by

IndustryARC

Apr 19, 2016, 10:30 ET

HYDERABAD, India and MINNEAPOLIS, USA, April 19, 2016 /PRNewswire/ --

According to the report, "Computational Medicine & Drug Discovery Software Market Analysis: By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - Forecast (2015 - 2020)", the computational medicine and drug discovery market is estimated to reach $6.78 Billion by 2020 at a high CAGR.

PR NEWSWIRE EUROPE - IndustryARC Logo (PRNewsFoto/IndustryARC)
PR NEWSWIRE EUROPE - IndustryARC Logo (PRNewsFoto/IndustryARC)

     (Logo: http://photos.prnewswire.com/prnh/20141106/712194 )

Browse - 21 Market Tables, 47 Figures spread through 158 Pages and an in-depth TOC on "Computational Medicine and Drug Discovery Software Market - Global Forecast to 2020".

http://industryarc.com/Report/1252/computational-medicine-drug-discovery-software-market-analysis.html

Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.  The Database referred to is basically a repository of information, which is used, in constraint-based models to understand protein-ligand interaction. With the introduction of computers, the implementation became easy in this field. As such theoretical chemistry transformed into computational chemistry and it was used to understand the interaction between biological molecules and drugs.

Inquiry before buying report @ http://www.industryarc.com/inquiry-before-buying.php?id=1252

According to recent report by IndustryARC, the computational medicine and drug discovery market is poised to grow at a CAGR of 5.1% to reach $6.78 Billion by 2020. Bioinformatics has made it possible to integrate and analyse large datasets in developing better treatment for chronic diseases such as Cancer. Predictive Analysis of Drug Targets and Disease Modelling will be the fastest growing applications.

Cloud and Mobile Platforms Provides Investment Opportunities 

Information technology has been assisting the research organizations to enhance collaborative efforts, managing workflows, enabling dynamism in the processes, handling larger volumes of data and decision making. The time taken for drug discovery and development has been reduced considerably in the past two decades with the advent of fast, accurate and user friendly computational platforms. Cloud computing refers to computational platform/repository that allows remote access of large volumes of data which is available for few or more users.

The presence of data access through cloud has been gaining prominence mainly due to the involvement of several stake holders, various functional departments within the organizations in the research process. In addition, for multi-national companies which have decentralized operations; streamlining of dynamic workflows becomes difficult. Furthermore, with the research contribution becoming more globalized due to the participation of research entities from various regions, the need for common research platform is on the spotlight.

Cloud and mobile computing of software and database that forms a right solution for aforementioned needs, with focus on convenience, flexibility, remote-access and real time data is required. According to the industry statistics, around 83% of the health care organizations are using at least one cloud based application. Application providers have a great opportunity to enter these highly potential markets by developing new products that run on cloud and mobile platforms. In addition, they can also enhance their existing products to make them compatible with these efficient platforms to cater to the evolving needs of pharma and biotech customers.

Request Sample Brochure @ http://www.industryarc.com/pdfdownload.php?id=1252

The Prominent Players Profiled in Computational Medicine and Drug Discovery Software Market Report are: 

  • Compugen Ltd. 
  • Chemical Computing Group Inc. 
  • Genedata AG  
  • Nimbus Therapeutics Inc.  
  • Schrodinger LLC 

The Market Segmentation by Geography:  

  • Americas - U.S., Canada & Rest of America
  • Asia pacific - Australia, China, Japan, Korea, Japan & Rest of APAC
  • Europe - U.K, Germany, The Netherlands, Norway, Italy,  & Rest of Europe
  • RoW 

Browse Related Reports: 

About IndustryARC: 

IndustryARC is a Research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Media Contact
Mr. Sanjay Matthews
Sales Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)

Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc
Browse Market Research Reports - http://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

SOURCE IndustryARC